Highlights and Quick Summary
Current Net Cash/Marketcap of Beam Therapeutics Inc. is $-0.16 (as of December 31, 2021)
- Net Cash/Marketcap for the quarter ending September 30, 2022 was $-0.274 (a -24.78% decrease compared to previous quarter)
- Year-over-year quarterly Net Cash/Marketcap increased by 71.26%
- Annual Net Cash/Marketcap for 2021 was $-0.16 (a 216.24% increase from previous year)
- Annual Net Cash/Marketcap for 2020 was $-0.0505 (a -89.88% decrease from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Cash/Marketcap of Beam Therapeutics Inc.
Most recent Net Cash/Marketcapof BEAM including historical data for past 10 years.Interactive Chart of Net Cash/Marketcap of Beam Therapeutics Inc.
Beam Therapeutics Inc. Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $0.0 | – |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | – | $0.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology